Irene Larripa

2.2k total citations
138 papers, 1.6k citations indexed

About

Irene Larripa is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Irene Larripa has authored 138 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Hematology, 58 papers in Molecular Biology and 33 papers in Genetics. Recurrent topics in Irene Larripa's work include Acute Myeloid Leukemia Research (36 papers), Chronic Myeloid Leukemia Treatments (35 papers) and Chronic Lymphocytic Leukemia Research (22 papers). Irene Larripa is often cited by papers focused on Acute Myeloid Leukemia Research (36 papers), Chronic Myeloid Leukemia Treatments (35 papers) and Chronic Lymphocytic Leukemia Research (22 papers). Irene Larripa collaborates with scholars based in Argentina, Brazil and United Kingdom. Irene Larripa's co-authors include Carlos Daniel De Brasi, Irma Slavutsky, Liliana Carmen Rossetti, Nora Gorla, Marcela González Cid, Claudia Pamela Radic, Hugo Garcı́a Ovando, G Barbieri, Marta Dolores Mudry and Michele Bianchini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Irene Larripa

132 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irene Larripa Argentina 20 785 615 238 219 185 138 1.6k
Richard D. Leavitt United States 14 1.1k 1.3× 954 1.6× 109 0.5× 286 1.3× 93 0.5× 25 2.0k
Zhijian Xiao China 23 775 1.0× 560 0.9× 189 0.8× 302 1.4× 61 0.3× 117 1.5k
Thayer White United States 22 1.5k 1.9× 1.0k 1.7× 117 0.5× 213 1.0× 357 1.9× 30 2.7k
T. R. Rutherford United Kingdom 18 682 0.9× 385 0.6× 96 0.4× 438 2.0× 125 0.7× 41 1.4k
Kajsa Paulsson Sweden 33 1.0k 1.3× 1.1k 1.8× 317 1.3× 265 1.2× 369 2.0× 88 2.8k
Raquel Ciuvalschi Maia Brazil 23 765 1.0× 339 0.6× 185 0.8× 268 1.2× 33 0.2× 96 1.5k
Kevin L. Peterson United States 22 1000 1.3× 172 0.3× 393 1.7× 82 0.4× 36 0.2× 40 1.6k
Søren E. Bjørn Denmark 19 534 0.7× 486 0.8× 108 0.5× 161 0.7× 74 0.4× 37 1.4k
P. Lambin France 22 498 0.6× 483 0.8× 38 0.2× 194 0.9× 167 0.9× 93 1.6k
Markus M. Weck Germany 18 529 0.7× 189 0.3× 94 0.4× 121 0.6× 45 0.2× 18 1.4k

Countries citing papers authored by Irene Larripa

Since Specialization
Citations

This map shows the geographic impact of Irene Larripa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Larripa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Larripa more than expected).

Fields of papers citing papers by Irene Larripa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Larripa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Larripa. The network helps show where Irene Larripa may publish in the future.

Co-authorship network of co-authors of Irene Larripa

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Larripa. A scholar is included among the top collaborators of Irene Larripa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Larripa. Irene Larripa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zapata, Pedro Darío, et al.. (2023). Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia. Gene. 896. 148047–148047.
3.
Furtado, Carolina, Patricio Yankilevich, Beatriz Moiraghi, et al.. (2021). miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool. Frontiers in Pharmacology. 11. 612573–612573. 10 indexed citations
4.
Radic, Claudia Pamela, Daniela Neme, Irene Larripa, et al.. (2019). Inverse PCR to perform long-distance haplotyping: main applications to improve preimplantation genetic diagnosis in hemophilia. European Journal of Human Genetics. 27(4). 603–611. 1 indexed citations
5.
Rossetti, Liliana Carmen, R. Bianco, Irene Larripa, et al.. (2012). Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B. Thrombosis and Haemostasis. 109(1). 24–33. 31 indexed citations
6.
Larripa, Irene, et al.. (2009). Alteraciones genéticas, inestabilidad genómica y cáncer en enfermedad celíaca. SHILAP Revista de lepidopterología. 39(1). 55–62. 1 indexed citations
7.
Bitton, Roberto, et al.. (2007). LEUCEMIA MIELOIDE CRONICA MECANISMOS GENETICOS DE RESISTENCIA AL IMATINIB. Medicina-buenos Aires. 67. 71–74.
9.
Gorla, Nora, et al.. (2004). Non-Random Distribution of Spontaneous Chromosome Aberrations in two Bloom Syndrome Patients. Hereditas. 122(3). 239–243. 13 indexed citations
11.
Rossetti, Liliana Carmen, et al.. (2004). Analysis of factor VIII gene intron 1 inversion in Argentinian families with severe haemophilia A and a review of the literature. Blood Coagulation & Fibrinolysis. 15(7). 569–572. 19 indexed citations
12.
Bowen, D. J., Carlos Daniel De Brasi, Irene Larripa, & Peter W. Collins. (2000). A new polymorphism in the human factor VIII gene: implications for linkage analysis in haemophilia A and for the evolution of int22h sequences. British Journal of Haematology. 111(2). 544–548. 7 indexed citations
13.
Mudry, Marta Dolores, et al.. (1994). Mutagenic bioassay of certain pharmacological drugs: III. Metronidazole (MTZ). Mutation research. Fundamental and molecular mechanisms of mutagenesis. 305(2). 127–132. 41 indexed citations
14.
Guerra, Liliana N., José Mordoh, Irma Slavutsky, Irene Larripa, & Estela E. Medrano. (1989). Characterization of IIB‐MEL‐J: A New and Highly Heterogenous Human Melanoma Cell Line. Pigment Cell Research. 2(6). 504–509. 32 indexed citations
15.
Gorla, Nora, et al.. (1989). Thirteenfold increase of chromosomal aberrations non-randomly distributed in chagasic children treated with nifurtimox. Mutation Research/Genetic Toxicology. 224(2). 263–267. 57 indexed citations
16.
Larripa, Irene, et al.. (1989). Coincidence in fragile site expression with fluorodeoxyuridine and bromodeoxyuridine. Cancer Genetics and Cytogenetics. 41(1). 41–48. 18 indexed citations
17.
Slavutsky, Irma, et al.. (1988). Heterochromatic variants and their association with neoplasias: V. Non-Hodgkin's lymphomas. Cancer Genetics and Cytogenetics. 31(2). 175–178. 7 indexed citations
18.
Larripa, Irene, et al.. (1983). Sister chromatid exchanges in a human population accidentally exposed to an organophosphorus pesticide. Revista brasileira de genetica. 6(4). 719–727. 8 indexed citations
19.
Damonte, Elsa B., et al.. (1979). Características virológicas y citogenéticas de células vero infectadas persistentemente con virus tacaribe. Medicina-buenos Aires. 39(5). 589–596. 2 indexed citations
20.
Larripa, Irene, et al.. (1978). [Cytogenetic analysis of Vero cell lines].. PubMed. 38(5). 513–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026